Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised …

…, J Revesz, G Bodoky, T Csoszi, A Csejtei… - The Lancet …, 2021 - thelancet.com
Background PD-1 and PD-L1 inhibitors are active in metastatic urothelial carcinoma, but
positive randomised data supporting their use as a first-line treatment are lacking. In this study …

[HTML][HTML] Radiotherapy of breast cancer—professional guideline 1st Central-Eastern European professional consensus statement on breast cancer

…, M Chorváth, A Ligačová, A Csejtei… - Pathology and …, 2022 - por-journal.com
The international radiotherapy (RT) expert panel has revised and updated the RT guidelines
that were accepted in 2020 at the 4th Hungarian Breast Cancer Consensus Conference, …

[HTML][HTML] Changing trends in melanoma incidence and decreasing melanoma mortality in Hungary between 2011 and 2019: a nationwide epidemiological study

…, R Gyulai, J Oláh, P Holló, G Emri, A Csejtei… - Frontiers in …, 2021 - frontiersin.org
Background The incidence of malignant melanoma has continually increased during the past
few decades, however, certain reports suggest a recent change in trends. The aim of our …

Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary

…, Z Orsos, K Gombos, B Bogner, A Csejtei… - Anticancer …, 2007 - ar.iiarjournals.org
Background: Genetic polymorphisms of metabolizing enzymes may affect the risk of cancer
formation in humans. Since the diet can contain polycyclic aromatic hydrocarbons (PAHs) …

Association of pre-miR-146a rs2910164 polymorphism with the risk of head and neck cancer

Z Orsos, I Szanyi, A Csejtei, I Gerlinger… - Anticancer …, 2013 - ar.iiarjournals.org
Background: Over- or underexpression of miR-146a has been reported in several different
human tumor types, and a polymorphism in its precursor form (pre-miR-146a rs2910164 G/C) …

GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer

A Csejtei, A Tibold, Z Varga, K Koltai, A Ember… - Anticancer …, 2008 - ar.iiarjournals.org
Background: Cancer of the colorectal region is the second most frequent cause of death
among malignant diseases. The influence of two allelic polymorphisms of GSTM1 and GSTT1, …

Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population

A Csejtei, A Tibold, K Koltai, Z Varga, I Szanyi… - Anticancer …, 2009 - ar.iiarjournals.org
Background: Head and neck cancer is a significant current health problem in Hungary because
the mortality of this cancer has increased by 387% in the last thirty-two years. Because of …

Assessment of the role of everolimus therapy in patients with renal cell carcinoma based on daily routine and recent research results

A Maráz, A Csejtei, J Kocsis, M Szűcs, Z Kahán… - Pathology & Oncology …, 2019 - Springer
Everolimus is indicated for adults with metastatic renal cell carcinoma (mRCC) after failure
of vascular endothelial growth factor receptor-tyrosine kinase inhibitors (TKI). Currently, the …

[HTML][HTML] Improving quality indicator of melanoma management–change of melanoma mortality-to-incidence rate ratio based on a Hungarian Nationwide retrospective …

…, R Gyulai, J Oláh, P Holló, G Emri, A Csejtei… - Frontiers in …, 2021 - frontiersin.org
Introduction The incidence of melanoma has been increasing in the last decades. A retrospective
Hungarian epidemiological study provided real-world data on incidence and mortality …

Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019

…, J Oláh, P Holló, G Emri, A Csejtei… - Journal of the …, 2023 - Wiley Online Library
Background Recent real‐world studies have reported significant improvements in the
survival of malignant melanoma in the past few years, mainly as a result of modern therapies. …